Diets · Metabolic & Cardiometabolic
time-restricted eating improves insulin sensitivity
In plain terms: Does eating earlier in the day improve insulin response?
Part of: 🥗 time-restricted eating
Probably modestly yes, but only from small short trials and the effect doesn't always hold.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Early time-restricted feeding (morning-aligned window) improved insulin sensitivity weight-independently in small supervised trials - the most credible 'timing matters' signal - but it is fragile and not always maintained.
The evidence (21)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Park J, Kim MS, Boo YK 2026 · Nutrition Reviews | meta-analysis | mixed | moderate | TRE improved several cardiovascular/NAFLD risk markers in overweight adults but effects on insulin endpoints were inconsistent across trials. |
| Søndergaard AM, Kjærulff MLG, Gormsen LC, Søndergaard E 2026 · American journal of physiology. Cell physiology | observational | mixed | moderate | Mini-review of RCTs/meta-analyses on TRE cardiometabolic effects: modest weight loss vs ad libitum but no consistent benefit vs caloric restriction; effects on glycemic control and insulin sensitivity are 'generally small, variable, and con |
| Peters B, Schwarz J, Schuppelius B, Ottawa A, Koppold DA, Weber D, Steckhan N, Mai K, Grune T, Pfeiffer AFH, Michalsen A, Kramer A, Pivovarova-Ramich O 2025 · Sci Transl Med | RCT | contradicts | high | Randomized crossover, n=31 women with overweight/obesity, 2-wk eTRE (8:00-16:00) vs 2-wk lTRE (13:00-21:00), intended isocaloric. Insulin sensitivity: between-arm -0.07 (95% CI -0.77 to 0.62); within eTRE 0.31 (-0.14 to 0.76), within lTRE 0.19 (-0.22 to 0.60) - all null. Authors: 'neither eTRE nor lTRE improves insulin sensitivity'. Caveat: 2-wk arms, no habitual-eating control arm, so TRE-vs-baseline is within-arm pre-post; small unintended deficit (eTRE -167 kcal/d). |
| Liu J, Yi P, Liu F 2023 · J Clin Endocrinol Metab | RCT | supports | moderate | Early TRE produced greater weight loss and metabolic-health gains, including insulin resistance, vs later TRE over the trial period. |
| Qin Y, Li X, Wang L, Shuang F, Jin X, Qu T, Wang Y, Wu Y, Tian J, Qian Y, Lv Q, Wang Z, Wang Y, Xing Y 2026 · Frontiers in aging | observational | supports | low | n=23 males with metabolic syndrome, 1-month eTRE intervention (same cohort design as companion brain-imaging study); BMI, fasting glucose, and lipid profiles improved (p<0.05); primary endpoints were brain-aging/memory, not insulin sensitiv |
| Rehman Z, Altonji OM, Steger FL, Jamshed H, Richman JS, Warriner AH, Peterson CM 2026 · J Nutr | RCT | mixed | moderate | Secondary analysis: eTRE benefits on cardiometabolic markers varied by phenotype/age/sex/race, so insulin-sensitivity gains are not uniform. |
| Alum EU 2025 · Journal of health, population, and nutrition | observational | supports | low | Narrative review (2013-2025 literature) on circadian-aligned eating: cites animal models with isocaloric controls and human trials associating higher energy intake earlier in the day / avoiding late-night eating with improved insulin sensit |
| Schimenes BC, Alvarenga TA, Tufik SB, Tufik S, Andersen ML 2026 · Frontiers in nutrition | observational | mixed | moderate | Mini narrative review: TRE improves glycemic control/insulin sensitivity in some studies, some effects independent of weight loss, but 'many identified advantages appear to be largely driven by spontaneous caloric restriction' with several |
| Harvie M, Coe P, Higham C, Peach N, Howell A, Evans DG, Williams S, Sellers K, Malcomson L, Pegington M, Renehan AG 2025 · BMC Nutr | RCT | tested-null | low | RCT: IER insulin-sensitivity gains NOT maintained across normal-eating days |
| Lu L, Chen X, Liou S, Weng X 2025 · J Health Popul Nutr | meta-analysis | supports | moderate | GRADE-assessed meta-analysis: intermittent fasting improved insulin resistance, lipids and inflammation in metabolic syndrome. |
| Tricò D, Masoni MC, Baldi S, Cimbalo N, Sacchetta L, Scozzaro MT, Nesti G, Mengozzi A, Nesti L, Chiriacò M, Natali A 2024 · Diabetologia | RCT | tested-null | moderate | Open-label RCT, n=27 randomised (23 completers) T2D with overweight, 12 wk: early time-restricted carbohydrate consumption (carbs at breakfast/lunch, dinner of protein/fat plus fruit/vegetables, 3 meals/day) vs Mediterranean diet, both with matched energy restriction. Insulin sensitivity (HOMA-IR, Matsuda) 'similarly increased by the diet in both groups'; HbA1c -3 vs -4 mmol/mol (p=0.386). Not a restricted eating window: the eTRC arm ate dinner, so this tests carbohydrate timing, not time-restricted eating. |
| Wong PS, Wan K, Dai Z, Yu AP, Wong SH, Poon ET 2025 · Nutrition Reviews | meta-analysis | supports | moderate | Meta-analysis of 16/8 TRE: overall improvement in fasting glucose, HOMA-IR, insulin and HDL-C vs comparators. |
| Jin X, Feng L, Li X, Qu T, Wu Y, Wang Z, Hui K, Guo H, Chen L, Wang L, Wang Y 2026 · Frontiers in nutrition | observational | supports | low | n=21 males with metabolic syndrome, 1-month early time-restricted eating (eTRE) intervention. Fasting insulin and HOMA-IR significantly decreased and QUICKI (insulin-sensitivity index) increased (all p<0.01), alongside weight/BMI/glucose de |
| Jamshed H, Beyl RA, Della Manna DL, Yang ES, Ravussin E, Peterson CM 2019 · Nutrients | RCT | mixed | low | Crossover n=11: early window lowered 24h glucose, raised autophagy/clock-gene expression |
| Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM 2018 · Cell Metab | RCT | supports | low | Supervised eucaloric crossover n=8 prediabetic men: 6h early window improved insulin sensitivity & BP (weight held) |
| Xie Z, Sun Y, Ye Y, Hu D, Zhang H, He Z, Zhao H, Yang H, Mao Y 2022 · Nature Communications | RCT | supports | moderate | In non-obese adults, early TRF improved insulin sensitivity and fasting glucose more than mid-day TRF; eTRF favored over mTRF for insulin resistance. |
| Wu H, Shi Y, Wang Z, Wei Z, Cui C, Xiong H, Wang Z, Ren J 2025 · Frontiers in medicine | observational | supports | moderate | Narrative review of TRE trials 2015-2025 for healthy aging: reports body-weight and HbA1c improvements (0.3-0.5%) attributable to combined calorie-restriction + timing effects; notes early eating window (eTRE) shows 'relative advantages' du |
| Khalafi M, Habibi Maleki A, Ghasemi F, Ehsanifar M, Symonds ME, Rosenkranz SK, Tinsley GM, Malek MK, Vakil S, Rafiei H 2026 · Rev Endocr Metab Disord | meta-analysis | supports | moderate | Network meta-analysis: intermittent-fasting types improved glycemic control in adults with overweight/obesity; TRE among effective approaches. |
| Huang L, Chen Y, Wen S, Lu D, Shen X, Deng H, Xu L 2023 · Food Sci Nutr | meta-analysis | supports | moderate | Meta-analysis of 8/16 TRE: benefits for weight and some metabolism markers but limited/uncertain effect on insulin sensitivity specifically. |
| Kramer CK, Zinman B, Feig DS, Retnakaran R 2025 · J Clin Endocrinol Metab | RCT | supports | moderate | TRE improved beta-cell function in adults with type 2 diabetes, consistent with better insulin handling. |
| Zaman A, Grau L, Jeffers R, Steinke S, Catenacci VA, Cornier MA, Rynders CA, Thomas EA 2024 · Obesity Sci Pract | RCT | contradicts | low | Secondary analysis (first 12 wk) of an RCT (NCT03571048): 81 adults with overweight/obesity randomised to early TRE plus daily caloric restriction vs daily caloric restriction alone; HOMA-IR analysable in 38. Weight-adjusted HOMA-IR change: DCR -0.4 (SD 0.7) vs E-TRE+DCR -0.3 (SD 0.6), group x time p=0.666 - a clean null with the point estimate slightly favouring DCR; fasting insulin, glucose, A1c also no difference; MAGE fell more with DCR (p=0.03). Adding an early window to matched caloric restriction did not improve insulin sensitivity. Low baseline insulin resistance (HOMA-IR ~1.6) and 47% data completeness limit sensitivity. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.